TCV-309 is an antagonist for platelet activating factor (PAF). TCV-309 improves the left ventricular function during ischemia-reperfusion (77.6% recover at 1 µM), protects the cardiac function[1].
Molecular Weight:
656.52
CAS Number:
[131311-25-6]
Formula:
C30H34BrN5O7
Target:
Platelet-activating Factor Receptor (PAFR)
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted